KemPharm, Inc.

Historical 13F Holders

Symbol
ZVRA
CUSIP
488445206
All holders as of
Q2 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 488445206 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
8.3% 8/6/2026
Event 6/30/2026
Woodline Partners LP 13G/A 8.1% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G/A 7.6% 2/5/2025
Event 12/31/2024
Vanguard Capital Management LLC 13G 5.1% 7/31/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Nantahala Capital Management, LLC 13G/A
4.4% 2/14/2025
Event 12/31/2024
Adage Capital Management, L.P. 13G/A
4.0% 11/13/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 4 921 $10.1 k
2026 Q2 169 46.6 M $669 M
2026 Q1 159 41.3 M $385 M
2025 Q4 172 38.1 M $342 M
2025 Q3 182 40.4 M $384 M
2025 Q2 130 36.5 M $322 M
2025 Q1 122 35.5 M $272 M
2024 Q4 116 33.9 M $283 M
2024 Q3 119 29.0 M $202 M
2024 Q2 102 18.5 M $90.8 M
2024 Q1 97 14.1 M $81.8 M
2023 Q4 95 15.3 M $100 M
2023 Q3 85 10.8 M $59.5 M
2023 Q2 77 8.15 M $41.6 M
2023 Q1 66 6.15 M $33.8 M
2022 Q4 78 6.02 M $405 M
2022 Q3 77 6.69 M $41.8 M
2022 Q2 81 7.27 M $32.6 M
2022 Q1 95 9.03 M $45.5 M
2021 Q4 88 7.36 M $63.9 M
2021 Q3 83 7.83 M $73.1 M
2021 Q2 86 7.67 M $98.3 M
2021 Q1 64 2.34 M $22.0 M
2020 Q4 2 1.66 k $19.0 k
2020 Q3 1 410 $5.00 k
2020 Q2 1 410 $5.00 k
2020 Q1 1 410 $5.00 k
2019 Q4 1 410 $5.00 k
2019 Q3 1 410 $5.00 k
2019 Q2 1 410 $5.00 k
2019 Q1 1 410 $5.00 k